Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bootsma

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Annals of the Rheumatic Diseases|December 4, 2004
Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphomaJ Pijpe, G W van Imhoff, A Vissink, et al.
Annals of the Rheumatic Diseases|January 4, 2017
Presence of anticitrullinated protein antibodies in a large population-based cohort from the NetherlandsA van Zanten, S Arends, C Roozendaal, et al.
European Neurology|May 27, 1999
Regional specific changes of cerebral metabolism in systemic lupus erythematosus identified by positron emission tomographyB M de Jong, J Pruim, L G Sinnige, et al.
Arthritis and Rheumatism|September 6, 2005
Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II studyJ Pijpe, G W van Imhoff, F K L Spijkervet, et al.
Rheumatology (Oxford, England)|November 17, 2005
Clinical significance of quantitative immunohistology in labial salivary glands for diagnosing Sjogren's syndromeJ M van Woerkom, A A Kruize, P J Barendregt, et al.
Arthritis and Rheumatism|December 1, 1995
Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patientsA J Duits, H Bootsma, R H Derksen, et al.
Scandinavian Journal of Rheumatology|April 17, 2026
Does lacrimal gland ultrasound discriminate between Sjögren's disease and non-Sjögren's sicca patients?Nrf Sluijpers, T Yang, A J Stel, et al.
Annals of the Rheumatic Diseases|January 30, 2014
Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study)P M Meiners, A Vissink, F G M Kroese, et al.
Annals of the Rheumatic Diseases|July 19, 2013
Predominantly proinflammatory cytokines decrease after B cell depletion therapy in patients with primary Sjogren's syndromeR P E Pollard, W H Abdulahad, H Bootsma, et al.
The Biochemical Journal|March 7, 2002
Complete beta-oxidation of valproate: cleavage of 3-oxovalproyl-CoA by a mitochondrial 3-oxoacyl-CoA thiolaseMargarida F B Silva, Jos P N Ruiter, Henk Overmars, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Annals of the Rheumatic Diseases|December 4, 2004
Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphomaJ Pijpe, G W van Imhoff, A Vissink, et al.
Annals of the Rheumatic Diseases|January 4, 2017
Presence of anticitrullinated protein antibodies in a large population-based cohort from the NetherlandsA van Zanten, S Arends, C Roozendaal, et al.
European Neurology|May 27, 1999
Regional specific changes of cerebral metabolism in systemic lupus erythematosus identified by positron emission tomographyB M de Jong, J Pruim, L G Sinnige, et al.
Arthritis and Rheumatism|September 6, 2005
Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II studyJ Pijpe, G W van Imhoff, F K L Spijkervet, et al.
Rheumatology (Oxford, England)|November 17, 2005
Clinical significance of quantitative immunohistology in labial salivary glands for diagnosing Sjogren's syndromeJ M van Woerkom, A A Kruize, P J Barendregt, et al.
Arthritis and Rheumatism|December 1, 1995
Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patientsA J Duits, H Bootsma, R H Derksen, et al.
Scandinavian Journal of Rheumatology|April 17, 2026
Does lacrimal gland ultrasound discriminate between Sjögren's disease and non-Sjögren's sicca patients?Nrf Sluijpers, T Yang, A J Stel, et al.
Annals of the Rheumatic Diseases|January 30, 2014
Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study)P M Meiners, A Vissink, F G M Kroese, et al.
Annals of the Rheumatic Diseases|July 19, 2013
Predominantly proinflammatory cytokines decrease after B cell depletion therapy in patients with primary Sjogren's syndromeR P E Pollard, W H Abdulahad, H Bootsma, et al.
The Biochemical Journal|March 7, 2002
Complete beta-oxidation of valproate: cleavage of 3-oxovalproyl-CoA by a mitochondrial 3-oxoacyl-CoA thiolaseMargarida F B Silva, Jos P N Ruiter, Henk Overmars, et al.
Pageof 11